|Issue Date||01 Sep 2021 - 03 Sep 2021|
|Issue Size||₹569.64 Cr|
|Market Lot||24 Shares|
|Shares on Offer||60,59,600|
|Subject to Sauda||₹2200-2400|
|Listing Date||14 Sep 2021|
With the founding of Ami Group, they embarked on a mission to convert rational capital into speciality chemicals for Agrochemicals, Cosmetics & Polymers. Ami Organics Limited is dedicated effectively meet your expectations of comprehensive portfolio of varied products, custom synthesis, or contract manufacturing in your prospective projects. Ami Organics Limited presently employs experienced and dedicated professionals who operate state-of-the-art production lines backed by advance testing facilities and latest equipment. They have grown to offer New Chemical Entity (NCE), along with large scale supply of pharma intermediates. They have established ourselves as the evolving player in providing pharmaceutical products in accordance with GMP standards as well as chemical production facility to cater. Fine & speciality chemicals having ISO standard. Devising to mark their presence in the international market, they are prepared to strengthen their co-operation and build future synergies with various organizations. Ami Organics Limited proposes the following commitments to its domestic and international customers.
The year was 2007, when they laid down the foundation of Ami Organics, a partnership firm which was later converted into a company Ami Organics Limited in 2007, keeping in mind the future requirements of pharma industry. Ever since the beginning, they stride towards becoming a pharmaceutical intermediate manufacturing facility that gathers best of the chemical and pharmaceutical inventions by using state-of- the-art technologies and installations. Ami Organics Limited is committed to the health care industry by supporting the development and commercialization of pharmaceutical intermediate products. Built on a foundation of highly focused and research-driven healthcare facility, Ami Organics Limited firmly believes in extending the services to maximize the impact on the global pharmaceutical industry. Ami Organics Limited develops Advance Pharma Intermediates for Active Pharmaceuticals Ingredients (APIs) to serve as many people as possible. Recently Ami Organics has acquired two manufacturing facilities of Gujarat Organics Limited situated at Ankleshwar and Jaghadia to strengthen & enhance its speciality and fine chemical portfolio to enter Agrochemical, Cosmetics & Polymer Industry. They are located in the western part of India in Gujarat state, with a strong market presence in more than 27 countries. Being an integrated supplier of Global Healthcare Products, Ami Organics Limited caters both, domestic and international market covering North & South America, Europe, and Asian Countries.
Nareshkumar Ramjibhai Patel, Chetankumar Chhaganlal Vaghasia, Shital Nareshbhai Patel and Parul Chetankumar Vaghasia are the company promoters.
|Total Assets (In ₹ Millions)||4,132.68||2,318.92||2,131.52|
|Total Revenue (In ₹ Millions)||3,419.88||2,424.86||2,388.96|
|Profit After Tax (PAT) (In ₹ Millions)||539.99||274.7||232.95|
|Date||GMP||Kostak||Subject to Sauda|
|03 Sep 2021||₹90-95||₹250||₹2200-2400|
|Date & Time||QIB||NII||RII||Total|
|Day 1 - 01 Sep 2021||1.39||0.40||2.82||1.90|
|Day 2 - 02 Sep 2021||1.43||1.51||6.32||3.90|
|Day 3 - 03 Sep 2021||86.64||154.81||13.36||64.54|
Please click the link below to check the IPO allotment status.IPO Allotment Status
Ami Organics Limited IPO will open on 01 Sep 2021 and close on 03 Sep 2021.
Ami Organics Limited IPO will list on 14 Sep 2021.
The offer price of Ami Organics Limited IPO is ₹603-610.
The lot size of Ami Organics Limited IPO is 24.
The Grey Market Premium (GMP) price of Ami Organics Limited IPO is ₹90-95.
The Kostak price of Ami Organics Limited IPO is ₹250.
The Subject to Sauda price for Ami Organics Limited IPO is ₹2200-2400.
Please Leave Your Message